Assessing and predicting cutaneous leiomyoma severity in hereditary leiomyomatosis and renal cell cancer syndrome: An observational study

Affiliations

• ¹ Faculty of Medicine and Health Sciences, McGill University, Montréal, Quebec, Canada.
• ² Division of Dermatology, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada.
• ³ Faculté de médecine de l'Université de Montréal, Montréal, Quebec, Canada.
• ⁴ Division of Dermatology, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada.
• ⁵ Division of Medical Genetics, Department of Specialized Medicine, McGill University, Montréal, Quebec, Canada.
• ⁶ Division of Clinical Epidemiology, Department of Medicine, McGill University, Montréal, Quebec, Canada; Centre for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada.
• ⁷ Department of Mathematics and General Sciences, Prince Sultan University, Riyadh, Saudi Arabia.
• ⁸ Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada; Division of Medical Genetics, Department of Specialized Medicine, McGill University, Montréal, Quebec, Canada; Cancer Research Program, Research Institute of the McGill University Health Centre, Montréal, Quebec, Canada; Department of Human Genetics, McGill University, Montréal, Quebec, Canada; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, Quebec, Canada.
• ⁹ Division of Dermatology, Department of Medicine, McGill University Health Centre, Montréal, Quebec, Canada; Division of Experimental Medicine, Department of Medicine, McGill University, Montréal, Quebec, Canada. Electronic address: elena.netchiporouk@mcgill.ca.